NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-116-2001-0-US-16 Formulation of Boronic Acid Compounds US CON 11/184,622 Abandoned
NIDCR E-127-1995-1-US-04 METHOD OF MODULATING TISSUE GROWTH USING FRZB PROTEIN US CON 11/184,005 7563596 Abandoned PDF
NIAID E-267-2004-1-IN-07 Vaccines Against AIDS Comprising CMV/R-Nucleic Acid Constructs IN National Stage 586/DELNP/2007 Abandoned
NIAID E-267-2004-1-CA-04 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs CA National Stage 2573702 Abandoned
NIAID E-267-2004-1-BE-19 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs BE EP 10182793.9 Abandoned
NIAID E-267-2004-1-IE-24 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs IE EP 10182793.9 Abandoned
NIAID E-267-2004-1-FR-22 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs FR EP 10182793.9 Abandoned
NIAID E-267-2004-1-DE-21 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs DE EP 10182793.9 Abandoned
NIAID E-267-2004-1-CH-20 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs CH EP 10182793.9 Abandoned
NIAID E-267-2004-1-GB-23 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs GB EP 10182793.9 Abandoned
NIAID E-267-2004-1-EP-11 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs EP DIV 10182793.9 Abandoned
NIAID E-267-2004-1-AU-02 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs AU National Stage 2005274948 Abandoned
NIAID E-267-2004-1-BE-13 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs BE EP 05791578.7 Abandoned
NIAID E-267-2004-1-CH-14 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs CH EP 05791578.7 Abandoned
NIAID E-267-2004-1-GB-17 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs GB EP 05791578.7 Abandoned
NIAID E-267-2004-1-FR-16 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs FR EP 05791578.7 Abandoned
NIAID E-267-2004-1-DE-15 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs DE EP 05791578.7 Abandoned
NIAID E-267-2004-1-IE-18 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs IE EP 05791578.7 Abandoned
NIAID E-267-2004-1-EP-06 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs EP National Stage 05791578.7 Abandoned
NIAID E-267-2004-1-JP-10 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs JP National Stage 2007-521694 Abandoned
NIAID E-267-2004-1-ZA-09 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs ZA National Stage 2007/01176 Abandoned
NIAID E-267-2004-1-PCT-01 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs PCT PCT COMB PCT/US2005/025219 Expired
NIDDK E-145-2002-1-US-01 Sigma-2 Receptor Agonists and their Use in the Treatment of HIV Infection US CIP 11/181,797 Abandoned
NCI E-062-2003-3-US-02 Use Of Smad3 Inhibitor In The Treatment Of Fibrosis Dependent On Epithelial To Mesenchymal Transition As In The Eye And Kidney US National Stage 11/183,194 Abandoned
NIAID E-267-2004-1-CN-05 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs CN National Stage 200580031207.4 Abandoned
NIAID E-267-2004-1-BR-03 Vaccine Against AIDS Comprising CMV/R-Nucleic Acid Constructs BR National Stage PI0513390-4 Abandoned
NCI E-140-2005-0-US-01 Induction of C/EBPalpha and Uses Thereof US 60/699,971 Abandoned
NCI E-180-2000-0-US-04 Specific Binding Agents for KSHV vIL-6 That Neutralize a Biological Activity US DIV 11/183,336 7108981 Abandoned PDF
NIEHS E-244-2006-0-US-01 Mouse Systems For Evaluating Antiviral Agent Toxicity US 60/699,413 Abandoned
NCI E-279-2004-0-PCT-02 Treatment of Viral Infections PCT PCT PCT/US2005/24893 Expired
NCI E-281-2004-0-PCT-02 Treatment of Viral Infections PCT PCT PCT/US2005/25176 Expired
NCI E-280-2004-0-PCT-02 Treatment of Viral Infections PCT PCT PCT/US2005/24922 Expired
NCI E-282-2004-0-PCT-02 Treatment of Viral Infections PCT PCT PCT/US2005/024892 Expired
NCI E-013-2002-0-US-03 Humanized Anti-Tag 72 CC49 for Diagnosis and Therapy of Human Tumors US National Stage 10/519,580 7569673 Abandoned PDF
NCI E-249-2004-1-PCT-01 DNA-Based Vaccination of Retroviral-Infected Individuals Undergoing Treatment PCT PCT COMB PCT/US2005/024498 Expired
NCI E-157-1997-0-US-18 IMMUNOTOXINS DIRECTED AGAINST MALIGNANT B CELLS US CON 11/179,844 Abandoned
NIAID E-056-2005-0-US-01 Porcine Rotovirus Gottfried-based Human Rotavirus VP4 (P1A And P12B) Single Gene Reassortant Vaccines In Addition To VP7 (G4, G5, G6, G8, G9 And G10) Single Gene Vaccines, Demonstrating Broad Reactivity US 60/698,572 Abandoned
NIDCR E-053-2002-0-HK-07 Methods and Compositions For The Promotion of Hair Growth Utilizing Actin Binding Peptides HK National Stage 05105748.9 Expired
NIAID E-272-2004-0-US-02 Protozoan Derived Compositions and Methods for Treating Autoimmune Disease US ORD 11/177,934 7510715 Abandoned PDF
NCI E-230-2002-2-US-03 Catalytic Domains Of Beta (1,4)-Galactosyltransferase I Having Altered Donor And Acceptor Specificities Domains, That Promote In Vitro Protein Folding And Methods For Their Use US National Stage 11/178,230 7482133 Expired PDF
NCI E-139-2005-1-US-01 Identification Of A Novel Binding Protein Binding Protein, FBP-1 US 60/697,685 Abandoned
NIAID E-263-2005-0-US-01 Poly-gamma-DL-glutamate Capsule Of Staphylococcus Edidermis US 60/697,646 Abandoned
NCI E-230-2002-2-JP-04 Catalytic Domains Of Beta (1,4)-Galactosyltransferase I Having Altered Donor and Acceptor Specificities, Domains That Promote In Vitro Protein Folding, and Methods For Their Use JP National Stage 2006-500866 Abandoned
NCI E-103-2005-1-US-01 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies US 60/697,655 Abandoned
NIAID E-066-2005-0-US-01 A Hexavalent Formulation Of A Bovine Or Rhesus Rotavirus-based Vaccine In A Schedule That May Eliminate Risk Of Intussusception US 60/697,435 Abandoned
NCI E-137-2005-0-US-01 METHODS AND COMPOSITIONS FOR TREATING FUS1RELATED DISORDERS US 60/697,596 Abandoned
NCI E-106-1993-0-JP-10 IMMUNOGENIC CHIMERAS COMPRISING NUCLEIC ACID SEQUENCES ENCODING ENDOPLASMIC RETICULUM SIGNAL SEQUENCE PEPTIDES AND AT LEAST ONE OTHER PEPTIDE, AND THEIR USES IN VACCINES AND DISEASE TREATMENTS JP DIV 2005-197523 Abandoned
NIDDK E-133-2005-0-US-01 Genomic Nucleic Acid Sequence for Cyanovirin-N and Signal Peptide Thereof US 60/696,599 Abandoned
NICHD E-353-2003-0-JP-05 Methods Of Treating And/or Preventing Autoimmune Diseases' JP National Stage 2004-565807 Abandoned
NIAID E-031-2004-3-US-01 Anti-Tubercular Drug: Compositions And Methods US CIP 11/173,192 7456222 Expired PDF